Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
oral
|
| gptkbp:approvalYear |
2013
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01XE13
|
| gptkbp:brand |
gptkb:afatinib
|
| gptkbp:chemicalFormula |
C24H25ClFN5O3
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gilotrif
|
| gptkbp:indication |
metastatic non-small cell lung cancer
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Boehringer_Ingelheim
|
| gptkbp:mechanismOfAction |
gptkb:receptor_tyrosine_kinase
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
rash stomatitis paronychia |
| gptkbp:target |
gptkb:EGFR
|
| gptkbp:usedFor |
gptkb:non-small_cell_lung_cancer
|
| gptkbp:bfsParent |
gptkb:afatinib
gptkb:Afatinib |
| gptkbp:bfsLayer |
7
|